Home Healthcare Pharmaceuticals Intravenous Iron Drugs Market

Intravenous Iron Drugs Market Size, Share & Trends Analysis Report By Product (Iron Dextran, Iron Sucrose, Ferric Carboxymaltose), By Application (Chronic Kidney Disease, Inflammatory Bowel Disease, Cancer) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Mitiksha Koul | Format: | Report Code: SR5075DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Intravenous Iron Drugs Market, By Product 2022-2034 (USD MILLION/ Units)
    1. Iron Dextran
    2. Iron Sucrose
    3. Ferric Carboxymaltose
  2. Intravenous Iron Drugs Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Chronic Kidney Disease
    2. Inflammatory Bowel Disease
    3. Cancer
  3. Regional Intravenous Iron Drugs Market
    1. North America
      1. North America Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
      2. North America Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Disease
        2. Inflammatory Bowel Disease
        3. Cancer
      3. U.S. Intravenous Iron Drugs Market
        1. U.S. Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. U.S. Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      4. Canada Intravenous Iron Drugs Market
        1. Canada Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Canada Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
    2. Europe
      1. Europe Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
      2. Europe Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Disease
        2. Inflammatory Bowel Disease
        3. Cancer
      3. U.K. Intravenous Iron Drugs Market
        1. U.K. Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. U.K. Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      4. Germany Intravenous Iron Drugs Market
        1. Germany Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Germany Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      5. France Intravenous Iron Drugs Market
        1. France Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. France Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      6. Spain Intravenous Iron Drugs Market
        1. Spain Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Spain Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      7. Italy Intravenous Iron Drugs Market
        1. Italy Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Italy Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      8. Russia Intravenous Iron Drugs Market
        1. Russia Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Russia Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      9. Nordic Intravenous Iron Drugs Market
        1. Nordic Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Nordic Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      10. Benelux Intravenous Iron Drugs Market
        1. Benelux Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Benelux Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      11. Rest of Europe Intravenous Iron Drugs Market
        1. Rest of Europe Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Rest of Europe Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
    3. APAC
      1. APAC Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
      2. APAC Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Disease
        2. Inflammatory Bowel Disease
        3. Cancer
      3. China Intravenous Iron Drugs Market
        1. China Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. China Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      4. Korea Intravenous Iron Drugs Market
        1. Korea Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Korea Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      5. Japan Intravenous Iron Drugs Market
        1. Japan Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Japan Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      6. India Intravenous Iron Drugs Market
        1. India Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. India Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      7. Australia Intravenous Iron Drugs Market
        1. Australia Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Australia Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      8. Singapore Intravenous Iron Drugs Market
        1. Singapore Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Singapore Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      9. Taiwan Intravenous Iron Drugs Market
        1. Taiwan Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Taiwan Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      10. South East Asia Intravenous Iron Drugs Market
        1. South East Asia Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. South East Asia Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      11. Rest of Asia-Pacific Intravenous Iron Drugs Market
        1. Rest of Asia-Pacific Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Rest of Asia-Pacific Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
    4. Middle East and Africa
      1. Middle East and Africa Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
      2. Middle East and Africa Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Disease
        2. Inflammatory Bowel Disease
        3. Cancer
      3. UAE Intravenous Iron Drugs Market
        1. UAE Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. UAE Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      4. Turkey Intravenous Iron Drugs Market
        1. Turkey Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Turkey Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      5. Saudi Arabia Intravenous Iron Drugs Market
        1. Saudi Arabia Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Saudi Arabia Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      6. South Africa Intravenous Iron Drugs Market
        1. South Africa Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. South Africa Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      7. Egypt Intravenous Iron Drugs Market
        1. Egypt Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Egypt Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      8. Nigeria Intravenous Iron Drugs Market
        1. Nigeria Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Nigeria Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      9. Rest of MEA Intravenous Iron Drugs Market
        1. Rest of MEA Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Rest of MEA Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
    5. LATAM
      1. LATAM Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
        1. Iron Dextran
        2. Iron Sucrose
        3. Ferric Carboxymaltose
      2. LATAM Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
        1. Chronic Kidney Disease
        2. Inflammatory Bowel Disease
        3. Cancer
      3. Brazil Intravenous Iron Drugs Market
        1. Brazil Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Brazil Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      4. Mexico Intravenous Iron Drugs Market
        1. Mexico Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Mexico Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      5. Argentina Intravenous Iron Drugs Market
        1. Argentina Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Argentina Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      6. Chile Intravenous Iron Drugs Market
        1. Chile Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Chile Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      7. Colombia Intravenous Iron Drugs Market
        1. Colombia Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Colombia Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
      8. Rest of LATAM Intravenous Iron Drugs Market
        1. Rest of LATAM Intravenous Iron Drugs Market By Product 2022-2034 (USD MILLION/ Units)
          1. Iron Dextran
          2. Iron Sucrose
          3. Ferric Carboxymaltose
        2. Rest of LATAM Intravenous Iron Drugs Market By Application 2022-2034 (USD MILLION/ Units)
          1. Chronic Kidney Disease
          2. Inflammatory Bowel Disease
          3. Cancer
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.